INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
68 hedge funds and large institutions have $13.9M invested in Infinity Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less capital invested
Capital invested by funds: $30.8M → $13.9M (-$16.9M)
Holders
68
Holding in Top 10
–
Calls
$155K
Puts
$29K
Top Buyers
| 1 | +$672K | |
| 2 | +$88K | |
| 3 | +$81.9K | |
| 4 |
GC
Gratus Capital
Atlanta,
Georgia
|
+$41.3K |
| 5 |
VF
Virtu Financial
New York
|
+$37K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$1M | |
| 3 | -$386K | |
| 4 |
BlackRock
New York
|
-$386K |
| 5 |
E
Ergoteles
New York
|
-$188K |